Atlas Trials

Functional Lung Avoidance Radiation Therapy Using Hyperpolarized Xenon-129 MRI

Clinical trial NCT05302817 · TERMINATED

Trial details

NCT number
NCT05302817
Sponsor
Xemed LLC
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Carcinoma, Non-Small-Cell Lung
Start date
2023-03-17
Primary completion
2025-02-28
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.